Longboard Pharmaceuticals Inc (LBPH)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
59.98 +0.02 (+0.03%) 11/29/24 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 59.98 unch (unch) -
for Fri, Nov 29th, 2024
Results
download Want to compare other data? Select Fields| Symbol | LBPH | MLTX | FOLD | ||
| Company | Longboard Pharmaceuticals Inc | Moonlake Immunotherapeutics | Amicus Therapeutics | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 59.99 | 36.82 | 7.89 | ||
| High | 60.03 | 38.56 | 7.89 | ||
| Low | 59.98 | 35.93 | 7.39 | ||
| Last | 59.98 | 37.21 | 7.50 | ||
| Change | +0.02 | -0.85 | -0.50 | ||
| % Change | +0.03% | -2.23% | -6.25% | ||
| Volume | 655,700 | 484,800 | 3,184,900 | ||
| 20-Day Average Volume | 866,510 | 514,755 | 2,950,735 | ||
| Previous Close | 59.96 | 38.06 | 8.00 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 59.78 | 38.81 | 8.60 | ||
| 20-Day Raw Stochastic | 95.87% | 26.47% | 5.88% | ||
| 20-Day Relative Strength | 76.13% | 40.89% | 27.64% | ||
| Weighted Alpha | +188.68 | -26.61 | -40.29 | ||
| Today's Opinion | 100% Buy | 100% Sell | 100% Sell | ||
| Previous Opinion | 100% Buy | 100% Sell | 100% Sell | ||
| Last Month's Opinion | 100% Buy | 88% Sell | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.35% since 11/21/24 | -6.65% since 03/28/25 | -11.03% since 03/28/25 | ||
| Low | 59.77 on 11/22/24 | 35.39 on 04/02/25 | 7.39 on 04/04/25 | ||
| High | 60.03 on 11/29/24 | 40.69 on 03/31/25 | 8.31 on 03/31/25 | ||
| 1-Month | |||||
| %Chg | +0.69% since 10/29/24 | -7.67% since 03/04/25 | -17.67% since 03/04/25 | ||
| Low | 58.82 on 11/04/24 | 35.39 on 04/02/25 | 7.39 on 04/04/25 | ||
| High | 60.03 on 11/29/24 | 42.26 on 03/24/25 | 9.26 on 03/20/25 | ||
| 3-Month | |||||
| %Chg | +68.77% since 08/29/24 | -30.38% since 01/03/25 | -20.30% since 01/03/25 | ||
| Low | 27.35 on 09/17/24 | 35.39 on 04/02/25 | 7.39 on 04/04/25 | ||
| High | 60.03 on 11/29/24 | 53.65 on 01/06/25 | 10.00 on 02/19/25 | ||
| 6-Month | |||||
| %Chg | +229.38% since 05/29/24 | -32.69% since 10/04/24 | -29.25% since 10/04/24 | ||
| Low | 15.64 on 06/10/24 | 35.39 on 04/02/25 | 7.39 on 04/04/25 | ||
| High | 60.03 on 11/29/24 | 58.26 on 12/17/24 | 12.65 on 11/06/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 2,341,979 | 2,381,887 | 2,304,300 | ||
| Shares Outstanding, K | 39,046 | 64,012 | 307,240 | ||
| Annual Sales | 0 | 0 | 528,300,000 | ||
| Annual Net Income | -54,420,000 | -118,940,000 | -56,110,000 | ||
| Last Quarter Sales | 0 | 0 | 149,710,000 | ||
| Last Quarter Net Income | -24,540,000 | -45,600,000 | 14,740,000 | ||
| 60-Month Beta | 1.07 | 1.32 | 0.79 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.63 on 11/07/24 | -0.72 on 02/26/25 | 0.09 on 02/19/25 | ||
| Latest Earnings Date | 11/07/24 | 05/06/25 | 05/08/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 133.33 | ||